We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Avg Time Held
1.5
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
401
Archer Daniels Midland
ADM
$40B
| $343K | 0.01% |
8,287
-290
| -3% | -$13.2K |
2014 Q3
4 quarters
|
|
402
State Street
STT
$44.8B
| $343K | 0.01% |
5,106
+14
| +0.3% | +$1.04K |
2013 Q2
9 quarters
|
|
403
Bank of New York Mellon
BNY
$96.7B
| $342K | 0.01% |
8,729
-800
| -8% | -$33.3K |
2014 Q1
6 quarters
|
|
404
Texas Instruments
TXN
$255B
| $341K | 0.01% |
6,889
-886
| -11% | -$43.2K |
2013 Q2
9 quarters
|
|
405
Eaton
ETN
$152B
| $340K | 0.01% |
6,621
+3,191
| +93% | +$188K |
2013 Q2
9 quarters
|
|
|
RDS.A
406
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $339K | 0.01% |
7,538
+30
| +0.4% | +$1.52K |
2014 Q1
6 quarters
|
|
407
DELISTED
The Charles Schwab Corporation
SCHW.PRB.CL
| $339K | 0.01% |
13,480
-2,070
| -13% | -$52.9K |
2015 Q1
2 quarters
|
|
408
Vanguard Morningstar Small-Cap Value ETF
VBR
$35.9B
| $337K | 0.01% |
3,475
| – | – |
2014 Q1
6 quarters
|
|
|
BPL
409
DELISTED
Buckeye Partners, L.P.
BPL
| $332K | 0.01% |
5,600
-35
| -0.6% | -$2.43K |
2013 Q2
9 quarters
|
|
410
General Motors
GM
$73.5B
| $325K | 0.01% |
10,841
-126
| -1% | -$3.86K |
2015 Q1
2 quarters
|
|
411
DELISTED
Paramount Global Class B
PARA
| $324K | 0.01% |
8,112
-7,920
| -49% | -$384K |
2013 Q2
9 quarters
|
|
412
American International
AIG
$42B
| $322K | 0.01% |
+5,670
| New | +$347K |
2015 Q3
0 quarters
|
|
413
Vodafone
VOD
$37.3B
| $322K | 0.01% |
10,160
| – | – |
2013 Q2
9 quarters
|
|
|
DKT.CL
414
DELISTED
Deutsche Bank Contingent Capital Trust V 8.05% Trust Pfd. Called
DKT.CL
| $322K | 0.01% |
11,505
| – | – |
2013 Q2
9 quarters
|
|
415
Avery Dennison
AVY
$13.3B
| $321K | 0.01% |
5,683
+175
| +3% | +$10.6K |
2013 Q3
8 quarters
|
|
416
DELISTED
Accelerate Diagnostics
AXDX
| $314K | 0.01% |
1,938
| – | – |
2013 Q4
7 quarters
|
|
417
Realty Income
O
$53B
| $309K | 0.01% |
6,729
+1,001
| +17% | +$45.2K |
2015 Q2
1 quarter
|
|
418
Black Hills Corp
BKH
$5.85B
| $308K | 0.01% |
7,450
| – | – |
2013 Q2
9 quarters
|
|
419
Constellation Brands
STZ
$22.2B
| $306K | 0.01% |
2,443
-708
| -22% | -$87.3K |
2013 Q2
9 quarters
|
|
|
NPSN
420
DELISTED
NASPERS LTD
NPSN
| $304K | 0.01% |
2,432
-895
| -27% | -$112K |
2014 Q4
3 quarters
|
|
421
DELISTED
BRF SA
BRFS
| $303K | 0.01% |
17,059
-10,703
| -39% | -$210K |
2014 Q1
6 quarters
|
|
|
STJ
422
DELISTED
St Jude Medical
STJ
| $303K | 0.01% |
4,800
-6,526
| -58% | -$466K |
2013 Q2
9 quarters
|
|
423
State Street Health Care Select Sector SPDR ETF
XLV
$45.7B
| $302K | 0.01% |
4,564
-104
| -2% | -$7.6K |
2014 Q3
4 quarters
|
|
424
J.M. Smucker
SJM
$13.5B
| $299K | 0.01% |
2,623
-769
| -23% | -$85.7K |
2014 Q1
6 quarters
|
|
425
Omnicom Group
OMC
$22B
| $298K | 0.01% |
4,517
| – | – |
2014 Q2
5 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.